Overview

Analyzing Female Trauma Exposed Responses to a Medication

Status:
Completed
Trial end date:
2014-10-31
Target enrollment:
Participant gender:
Summary
This purpose of this study is to look at the safety of the experimental drug GSK561679 as well as its effects on PTSD symptoms, thinking and memory, startle reaction, stress hormones, and mental health symptoms in comparison to placebo (an inactive substance).
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development